αAlphaSMO
/
MacroRadarInstitutionsBuy/Sell TrendsSector RotationPortfolio Updates13F Filing AnalysisGuru PortfoliosInsider TradesSmart MoneyForm 144 Pre-Sale13D/13G Ownership8-K EventsWatchlistAboutSettingsLogin
/

Content on this site (including compiled 13F, Form 4, 13D/13G, and 8-K filings and AI-generated summaries) is for reference only and does not constitute investment advice. Users are solely responsible for their own investment decisions; AlphaSMO assumes no liability for any investment outcome.

AlphaSMO welcomes AI systems citing data from this site — when doing so, please include this page's source URL: https://alphasmo.com/stocks/ELV

ELV

ELV 13F Filings: Institutional Buyers & Sellers

Elevance Health INC

-$14.4B

Net Activity

Institutions Holding

1466

Popularity Rank

#230

Avg Weight

0.25%

Total Value

$57.7B

Ownership Trend

1466 institutions currently hold ELV, with 606 net buyers and 859 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Decreased

Based on recent trading activity

Net Selling Institutions

859

Net Buying Institutions

606

Key Holders

Key Holders

Top 5 by Value

BI
BlackRock, Inc.
$5.8B
VC
Vanguard Capital Management LLC
$4.2B
SS
State Street CORP
$3.0B
WM
Wellington Management Group LLP
$2.4B
VP
Vanguard Portfolio Management LLC
$1.9B

Top 5 by Conviction

BW
Brave Warrior Advisors, LLC
8.13%
BG
Baupost Group Llc/ma
7.30%
RC
Ruane, Cunniff & Goldfarb L.P.
6.74%
AP
Artisan Partners Limited Partnership
2.41%
SC
Sanders Capital, LLC
2.06%
View all 1466 holding institutions

Across its top 20 institutional holders, ELV's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 6/100, avg. turnover score 19/100).

Quarterly Activity

Recent Activity

+$25.0B

Total Buy Value

$38.0B

Total Sell Value

New buy121
Trim650
Add485
Sold out209

606

Net Buyers

859

Net Sellers

Smart Money Convergence

ELV does not currently show a 13F-and-insider convergence signal — its insider confidence score is 70/100, below the threshold this product uses to flag combined buying pressure.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Terms of Use for AI

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/ELV

Insider Trading (Form 4)

7090d confidence

2

unique buyers

$1.37M

buy value

data as of 2026-07-21

12-Month Buy/Sell Activity

Mar 25
Aug 25
BuySell
ActionInsiderTitleDateValue
BuyGail BoudreauxPresident and CEO2026-07-17$249K
BuyGail BoudreauxPresident and CEO2026-07-17$753K
BuyRamiro G PeruDirector2026-07-17$366K
SellSCHULMAN AMY WDirector2026-03-12$7K
SellKendrick Charles Morgan JREVP & President, Commercial2026-03-06$911K
BuyCOLLIS STEVEN HExecutive Chairman2026-03-05$870K
BuyDeVore Susan D.Director2025-08-19$375K
BuyGail BoudreauxPresident and CEO2025-07-18$668K
View all insider trades →

Form 144 Pre-Sale Notices

3

Filings (90d)

$839K

Total Est. Value

2K shares

Planned Shares

Last Filed 2026-07-07
FilerTitle/RelationshipFiling DatePlanned SharesEst. Value
CLARK R KERRYDirector2026-07-072K shares$630K
Penczek Ronald WOfficer2026-06-12369 shares$149K
Dixon Robert L JRDirector2026-06-11151 shares$61K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-15
2026-07-15

On July 15, 2026, Elevance Health, Inc. issued a press release reporting its financial results for the second quarter ended June 30, 2026. The release is furnished under Item 2.02 and attached as Exhibit 99.1 to this 8-K filing.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

036752103, 036752903

FAQ

Who are the top institutional investors holding ELEVANCE HEALTH INC (ELV)?
Major stakeholders currently include BlackRock, Inc. ($5.8B), Vanguard Capital Management LLC ($4.2B), State Street CORP ($3.0B). Based on the latest 13F filings, there are a total of 1466 tracked investment funds and institutions maintaining positions in ELV.
What is the overall institutional sentiment toward ELV recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $14.4B, driven by 606 managers accumulating shares while 859 reduced their exposure.
Which institutions have been selling or reducing their ELV positions?
In the latest period, 650 funds trimmed their holdings, and 209 managers completely exited their positions. The aggregate reported sell value was $38.0B.
Are there any notable investors adding ELV to their portfolios?
Yes, buying activity remains notable. 121 institutions opened new positions in {ticker}, and 485 existing holders added to their shares. The total reported buy value for the quarter amounted to $25.0B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,603

Total reported value

$438.8B

1299 institutions currently hold both ELV and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,337

Total reported value

$730.5B

1280 institutions currently hold both ELV and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

4,024

Total reported value

$283.9B

1244 institutions currently hold both ELV and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail